SEGMENT
Loqtorzi Net Product Revenue
Coherus net product revenue in USD from LOQTORZI (toripalimab-tpzi), its marketed anti-PD-1 oncology treatment. Excludes other revenue, royalties, biosimilar businesses sold/discontinued and clinical milestones. Exact filing amounts take precedence over rounded highlights; source precision varies by observation.
loqtorziNetProductRevenue- Frequency
- quarterly / annual
- Reported history
- Q3'24 — Q2'26